Improving the outcomes of patients with AL amyloidosis and cardiac involvement

Panagiota-Efstathia Nikolaou, PhD, National and Kapodistrian University of Athens, Athens, Greece, shares her perspectives on optimizing the outcomes of patients with AL amyloidosis with cardiac involvement. Dr Nikolaou highlights the importance of multi-target therapies and multidisciplinary treatment approaches. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.